← Insider buys
XENE

Xenon Pharmaceuticals Inc. · Healthcare

Director Simon N. Pimstone sold $5.1M of Xenon Pharmaceuticals Inc.

Sold$5,104,970
$38.90Price
131,245Shares
−96%Stake

What XENE did after the filing

Filed Jun 1, copier in the same day
The stock from Thu, Jun 1 close, $38.65
+1.2%
S&P 500, same days
+7.3%

Measured over 30 trading days, to the Jul 17 close.

Traded Tue, May 30. Filed Thu, Jun 1, 3:25 PM ET, during the session. Returns use the Jun 1 close and the Jul 17 close. Not investment advice.